MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson joined Proactive to chat about the company's transition to commercialization from its R&D focus. He noted the commercialization of its biofertility product TerraSante, which has gained momentum in key US states. The CEO also discussed MustGrow's partnership with Bayer, which involves a commercial licensing agreement for their soil biopesticide TerraMG. Proactive: Some news today, talking in essence about what's going on within the company ...